[ad_1] Eli Lilly and Co. (LLY) may have problems with large acquisitions in the fourth quarter. The war chest of the 142-year-old pharmaceutical company was built largely by the IPO of its …
Read More »
[ad_1] Shares of Eli Lilly (LLY) fell after the release of the third quarter results before Tuesday morning's opening. The slide could present an interesting opportunity for bullish investors. The pharmaceutical giant …
Read More »
[ad_1] Hippocrates used it. Just like Pliny the Elder – and then Galen of Pergamos, perhaps the greatest physician-scientist of antiquity. Transmitted by the Greeks and Romans, the Sumerians, the Assyrians and …
Read More »
[ad_1] A new migraine medication developed by Eli Lilly & Co. (NYSE: LLY) has been approved by the US regulatory authorities. Galcanezumab, which will be marketed under the name Emgality, has been …
Read More »
[ad_1] The Food and Drug Administration has approved the injection of Eli Lilly (NYSE: LLY) for the preventive treatment of migraine in adults, one of three drugs in a new class recently …
Read More »
[ad_1] Eli Lilly shares rose 3% in pre-sale on Tuesday after the pharmaceutical company overtook second-quarter estimates and announced that it would file a first public offering for its unit of animal …
Read More »
[ad_1] Director Peyton Reed gave his leader a hard time at the premiere of Marvel Studios. Evangeline Lilly does not take on her Marvel superhero functions lightly. Ant-Man and the wasp Director …
Read More »